Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
CellX logo — Eat Meat, Not Animals. World's First Mushroom Protein from M...

CellX

Eat Meat, Not Animals. World's First Mushroom Protein from Morel Mycelium. Technology Enabler for Cultivated Meat.

Founded 2020 United States Shanghai, United States 24 employees Series A Total: $26.32M Agriculture, Biotechnology +1

General Information

Company Name CellX
Founded Year 2020
Location United States Shanghai, United States
Employees 24
Industries Agriculture, Biotechnology, Food and Beverage
Funding Stage Series A
Business Model B2B, Platform, White Label
Revenue Model Licensing, Product Sales
Social

BounceWatch is an independent company data service, not affiliated with CellX. To contact CellX, visit cellx.co.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About CellX

CellX is a Shanghai-based cellular agriculture startup aiming to revolutionize the food industry with its slogan "Eat Meat, Not Animals. Pioneer of Cultivated Meat in China." Established in 2020, the company has already made substantial progress, boasting a substantial $20M+ in funding and a formidable R&D team of 40 professionals. Their focus lies in developing core platform technologies with a multi-species approach, moving towards scaling up and cost reduction. Collaborating with esteemed universities and industry leaders globally, CellX is dedicated to advancing the commercialization of cultivated meat. The company is also intensively working on market launch and cultivation approval in the APAC region. As it secured a significant $6.50M Series A investment on 16 June 2023, it shows strong investor confidence in the potential of this disruptive venture. With a keen eye on sustainability, health, and animal welfare, CellX stands poised to make a lasting impact in the fields of Agriculture, Biotechnology, and Food and Beverage.

Taxonomy: Cultivated meat, Cellular agriculture, Sustainable protein, Animal welfare, R&D, Startup, Food technology, Health innovation, APAC market, University collaboration, Cost reduction, Scale-up, Investment, Commercialization

Services & Products

CellX focuses on developing and providing biotechnological solutions in regenerative medicine and sustainable food production
particularly through cell-based therapy and lab-grown meat technologies.

Target Customers

CellX targets industries involved in biotechnology pharmaceuticals and sustainable food production. Their services are relevant to companies looking for innovative approaches in regenerative medicine and eco-friendly meat alternatives as well as consumers seeking sustainable and health-oriented food options.

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $6.50M -
16 Jun 2023
Grant $417.50K 1
XPRIZE
10 May 2023
Series A $10.60M 5
Agronomics Lever VC Better Bite Ventures
Agronomics, Lever VC +3
16 May 2022
Seed Round $4.00M 2
LiquidMetal Ventures 观正资本 Better Bite Ventures
LiquidMetal Ventures 观正资本, Better Bite Ventures
01 Jun 2021
Seed Round $4.30M 6
Brinc ZhenFund Sky9 Capital
Brinc, ZhenFund +4
15 Mar 2021
Pre Seed Round $500.00K 4
Agronomics Lever VC Purple Orange Ventures
Agronomics, Lever VC +2
01 Aug 2020

CellX Alternatives & Competitors

View All Alternatives
CellX vs
Jimi Biotech
Jimi Biotech China

Jimi Biotech develops delicious meat directly from animal cells, without slaughtering.

Angel
10 employees
Biotechnology, Food and Beverage
CellX vs
New Age Meats
New Age Meats

Cultivating a healthier future with lab-grown meat, reducing the need for animal slaughter.

Series A
Biotechnology, Food and Beverage
CellX vs
MEATOSYS
MEATOSYS Germany

The organic cultivated meat

Pre-Seed
4 employees
Biotechnology, Food and Beverage
View all alternatives

FAQ About CellX

Eat Meat, Not Animals. World's First Mushroom Protein from Morel Mycelium. Technology Enabler for Cultivated Meat.
CellX was founded in 2020.
CellX is headquartered in Shanghai, United States.
CellX operates in Agriculture, Biotechnology and Food and Beverage. Its work centres on Cultivated meat, Cellular agriculture, Sustainable protein and Animal welfare. Its customers include CellX targets industries involved in biotechnology, pharmaceuticals and and sustainable food production. Their services are relevant to companies looking for innovative approaches in regenerative medicine and eco-friendly meat alternatives.
CellX has a B2B, Platform and White Label business model. Its revenue comes from Licensing and Product Sales.
CellX has approximately 24 employees.
CellX has completed 6 funding rounds, raising a total of $26.32M. The latest funding stage is Series A.
CellX offers: CellX focuses on developing and providing biotechnological solutions in regenerative medicine and sustainable food production, particularly through cell-based therapy and lab-grown meat technologies..
Top alternatives and competitors to CellX include Jimi Biotech, New Age Meats, MEATOSYS, Atlantic Fish Co, MIRAI FOODS. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CellX and Jimi Biotech are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CellX, https://bouncewatch.com/company/cellx, updated 19 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes